P H Kari

In vitro and in vivo biotransformation of simvastatin, an inhibitor of HMG CoA reductase.

S. Vickers, C A Duncan, Kamlesh P. Vyas et al. · Drug Metabolism and Disposition · 1990 · 154 citations

HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studies.

Peter F. Smith, R. S. Eydelloth, Scott Grossman et al. · Journal of Pharmacology and Experimental Therapeutics · 1991 · 147 citations

Biotransformation of lovastatin. V. Species differences in in vivo metabolite profiles of mouse, rat, dog, and human.

Rita A. Halpin, E H Ulm, A. E. Till et al. · Drug Metabolism and Disposition · 1993 · 54 citations

Biotransformation of lovastatin. I. Structure elucidation of in vitro and in vivo metabolites in the rat and mouse.

Kamlesh P. Vyas, P H Kari, Steven M. Pitzenberger et al. · Drug Metabolism and Disposition · 1990 · 47 citations

Biotransformation of lovastatin. II. In vitro metabolism by rat and mouse liver microsomes and involvement of cytochrome P-450 in dehydrogenation of lovastatin.

Kamlesh P. Vyas, P H Kari, Shimoga R. Prakash et al. · Drug Metabolism and Disposition · 1990 · 31 citations